News

The story of sweetgrass baskets is woven into the tradition of the Lowcountry, but MUSC’s display of the treasured heirlooms comes with even more of a twist.

As we head into the holiday season, another occasion is also upon us: flu season.

A seemingly everyday symptom eventually led to an unusual diagnosis.

Matt Dellinger turned down a clinical trial at first, thinking it was a last-ditch option. When he learned more about clinical trials, he became a proponent.

MUSC scientists have discovered, for the first time in people, a previously unknown pathway that helps the brain to drain away waste.

Hollings Cancer Center researchers have been awarded a federal grant to help people with HIV to quit smoking by changing practices in Ryan White clinics.

At MUSC, an artificial intelligence program is helping pathologists to analyze Pap smears more quickly and efficiently.

A highly sought-after clinical trial testing under-the-skin cochlear implants is expanding earlier than expected.

New tools out of MUSC take aim at current pitfalls and bottlenecks of collecting data for decentralized clinical trials and protecting their integrity.

Building on the success of its Charleston-based program, the Hollings Tobacco Treatment Program now has a pharmacist in Columbia.